F 0577
Allow residents to easily view the nursing home's survey results and communicate with advocate agencies.
Level of Harm - Potential for
minimal harm
Based on record review and staff interview, the facility failed to ensure the most recent state survey results
were readily available for public review. This had the potential to affect all 90 residents residing in the facility.
Residents Affected - Many
Findings included:
Review of the facility folder titled Ohio Department of Health Survey Results located in the main lobby in
clear view revealed the last survey in the folder and available to be reviewed by the public was the annual
survey conducted on 06/27/19.
The Ohio Department of Health conducted a complaint survey at the facility on 01/04/22 resulting in a
certification deficiency and licensure violation being issued to the facility:
Interview with the Administrator on 06/28/22 at 9:53 A.M. confirmed the last survey in the book was
06/27/19 for public review.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
365581
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365581
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/30/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Ohio Living Breckenridge Village
36855 Ridge Rd
Willoughby, OH 44094
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** #3: Record
review of Resident #23 revealed she was admitted to the facility on [DATE] and had diagnoses including
Alzheimer's Disease, cognitive communication deficit, restlessness and agitation, and acute psychosis. She
had an active order for 25 milligrams of Seroquel (an antipsychotic) to be given twice per day as needed
(PRN) for behaviors including hitting, scratching, and screaming. The order was dated 12/02/21. A
psychiatric service visit dated 05/26/22 noted her PRN seroquel order was to be continued. The surveyor
could not find evidence the PRN seroquel was specifically reviewed and renewed every 14 days.
Record review of Resident #23's medication administration record revealed she received the PRN seroquel
twice in April 2022 on 04/11/22 and 04/15/22, and no times in May or June 2022 as of the time of the
record review.
Review of a pharmacy record review for Resident #23 dated 01/28/22 revealed the pharmacy
recommendation that the PRN Seroquel order be made to only last 14 days, and to be renewed every 14
days. The provider checked 'disagree' on the response list at the bottom and wrote to continue the
medication as-ordered.
Review of the facility's psychotropic medication policy dated 03/01/21 revealed antipsychotic medications
were limited to 14 days and could not be renewed unless the physician evaluated the resident for
appropriateness for another 14 days.
The surveyor confirmed the above findings with the Director of Nursing on 06/29/22 at 10:25 A.M.
2. Review of the medical chart for Resident #3 revealed an admission date of 03/15/22. Diagnoses include
but not limited to vascular dementia without behavioral disturbance, torticollis, and brachial plexus
disorders. Review of the admission Minimum Data Set (MDS) 3.0 assessment, dated 03/22/22, revealed
Resident #3 had severely impaired cognition and required extensive assistance with two staff for activities
of daily living except eating required supervision with set up only.
Review of the physician's orders for June 2022 revealed Resident #3 was ordered 1.0 milligrams (mg) of
lorazepam on 03/16/22 for muscle spasm as needed (PRN) with a maximum dose of three tablets with no
stop date.
Interview on 06/30/22 at 8:07 A.M. with Registered Nurse (RN) #538 verified that there was no stop date for
lorazepam PRN.
Review of the facility policy titled, Psychotropic Medications, with a revised date of 03/01/21, revealed PRN
orders for psychotropic drugs are limited to 14 days except if the attending physician or prescribing
practitioner believes that it is appropriate for the PRN order to be extended beyond 14 days then he or she
will document their rationale in the resident's medical record and indicate the duration for the PRN order.
Based on record reviews and interviews the facility failed to ensure as needed medication orders for
psychotropic drugs were limited to 14 days. This affected three (Residents #3, #23, and #34) of six
residents reviewed for unnecessary medication. The census at the time of the survey was 90
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365581
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365581
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/30/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Ohio Living Breckenridge Village
36855 Ridge Rd
Willoughby, OH 44094
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
residents.
Level of Harm - Minimal harm
or potential for actual harm
Findings include:
Residents Affected - Few
1.Record review for Resident #34 revealed the resident was readmitted to the facility on [DATE]. Pertinent
diagnoses for the resident included unspecified dementia, other dissociative and conversion disorders,
cognitive communication deficit, chronic pain, anxiety disorder, and major depressive disorder. The brief
interview for mental status (BIMS) from MDS dated [DATE] revealed the resident had a score of five
indicating severe cognitive impairment.
Review of physician orders for Resident #34 revealed on 03/09/22 the physician had ordered the
antipsychotic medication Seroquel one 50 milligram (mg) tablet by mouth every six hours as needed (PRN)
for unspecified dementia with behavioral disturbance with no end date.
The medication administration record (MAR) for Resident #34 was reviewed for the month of June 2022
and had documented administrations of the PRN antipsychotic medication Seroquel as followed: one
administration on 06/04/22, one administration on 06/05/22, one administration on 06/10/22, one
administration on 06/20/22, one administration on 06/24/22, and one administration on 06/28/22.
The facility failed to provide evidence the physician had reviewed the continued and frequent use of the
PRN psychotic medication for Resident #34. No evidence was presented to confirm the 14 day
re-assessment and reorder interval was completed. These findings were verified during interview with the
Director of Nursing on 06/29/22 at 10:21 A.M.
Review of the facility policy titled, Psychotropic Medications, with a revised date of 03/01/21, revealed PRN
orders for psychotropic drugs are limited to 14 days except if the attending physician or prescribing
practitioner believes that it is appropriate for the PRN order to be extended beyond 14 days then he or she
will document their rationale in the resident's medical record and indicate the duration for the PRN order.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365581
If continuation sheet
Page 3 of 3